Dermapharm Holding SE
XMUN:DMP
Dermapharm Holding SE
XMUN:DMP
Kurs:
47,55
EUR
-1,86%
Markt geschlossen
Marktkap.:
€5,09 Mrd.
Notiz hinzufügen
Kursziel hinzufügen
Gedanken festhalten und ein Kursziel setzen
Legen Sie fest, zu welchem Kurs Sie kaufen würden. Wir helfen Ihnen, bereit zu bleiben.
Basierend auf
Sicherheitsmarge
0%
10%
20%
30%
40%
50%
Ihr Kursziel
Verknüpft mit
aktuellem Kurs
· In Kaufzone
Lädt
Notiz verknüpft
Wählen Sie die Aktie, die Sie mit einem Kursziel beobachten möchten
Zuletzt angesehen
|
D
|
Dermapharm Holding SE
XMUN:DMP
|
DE |
|
Calbee Inc
TSE:2229
|
JP |
Cashflow-Rechnung
Cashflow-Rechnung
Dermapharm Holding SE
Dermapharm Holding SE
Währung: EUR
| Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operativer Cashflow | ||||||||||||||||||||||||||||||||||||
| Nettogewinn |
57
|
24
|
78
|
79
|
76
|
75
|
75
|
73
|
77
|
74
|
110
|
128
|
129
|
142
|
125
|
138
|
175
|
226
|
293
|
301
|
271
|
261
|
216
|
229
|
196
|
158
|
106
|
100
|
130
|
142
|
172
|
158
|
164
|
172
|
184
|
|
| Abschreibungen |
21
|
15
|
16
|
17
|
21
|
5
|
23
|
9
|
18
|
34
|
47
|
47
|
47
|
46
|
44
|
21
|
21
|
22
|
45
|
56
|
84
|
85
|
95
|
97
|
92
|
99
|
102
|
106
|
95
|
95
|
87
|
87
|
85
|
85
|
92
|
|
| Veränderung latenter Steuern |
9
|
3
|
8
|
12
|
18
|
22
|
(1)
|
(8)
|
(16)
|
(19)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Sonstige nicht zahlungswirksame Posten |
45
|
50
|
4
|
4
|
7
|
6
|
11
|
12
|
11
|
12
|
10
|
11
|
13
|
13
|
14
|
13
|
10
|
0
|
3
|
(8)
|
(7)
|
3
|
22
|
36
|
54
|
65
|
68
|
63
|
47
|
53
|
44
|
47
|
56
|
45
|
37
|
|
| Gezahlte Steuern |
1
|
0
|
2
|
2
|
11
|
16
|
23
|
30
|
24
|
50
|
52
|
54
|
59
|
37
|
38
|
41
|
43
|
43
|
45
|
43
|
42
|
42
|
41
|
40
|
53
|
53
|
65
|
79
|
75
|
81
|
84
|
98
|
94
|
100
|
90
|
|
| Gezahlte Zinsen |
9
|
8
|
7
|
8
|
10
|
8
|
6
|
6
|
6
|
7
|
8
|
9
|
10
|
10
|
9
|
9
|
8
|
8
|
8
|
7
|
7
|
7
|
8
|
9
|
14
|
30
|
33
|
50
|
51
|
54
|
54
|
55
|
53
|
54
|
52
|
|
| Veränderung des Working Capital |
(11)
|
(7)
|
(19)
|
8
|
16
|
39
|
51
|
10
|
6
|
(15)
|
(67)
|
(72)
|
(93)
|
(98)
|
(51)
|
(56)
|
(67)
|
(65)
|
(91)
|
(97)
|
(100)
|
(80)
|
(45)
|
(39)
|
(39)
|
(45)
|
(57)
|
(91)
|
(84)
|
(93)
|
(102)
|
(119)
|
(89)
|
(96)
|
(84)
|
|
| Cashflow aus operativer Tätigkeit |
121
N/A
|
84
-31%
|
87
+4%
|
120
+38%
|
137
+15%
|
165
+20%
|
159
-4%
|
115
-27%
|
109
-5%
|
90
-18%
|
101
+12%
|
114
+13%
|
98
-14%
|
104
+6%
|
132
+26%
|
140
+6%
|
164
+18%
|
209
+27%
|
250
+20%
|
252
+1%
|
249
-1%
|
269
+8%
|
289
+7%
|
323
+12%
|
303
-6%
|
278
-8%
|
219
-21%
|
178
-19%
|
187
+5%
|
197
+5%
|
201
+2%
|
173
-14%
|
216
+25%
|
207
-4%
|
229
+11%
|
|
| Investitions-Cashflow | ||||||||||||||||||||||||||||||||||||
| Investitionsausgaben |
(26)
|
(76)
|
(75)
|
(75)
|
(76)
|
(22)
|
(26)
|
(31)
|
(38)
|
(38)
|
(46)
|
(45)
|
(40)
|
(43)
|
(41)
|
(42)
|
(49)
|
(56)
|
(61)
|
(62)
|
(58)
|
(47)
|
(39)
|
(35)
|
(37)
|
(39)
|
(42)
|
(42)
|
(42)
|
(40)
|
(38)
|
(41)
|
(40)
|
(42)
|
(42)
|
|
| Sonstige Posten |
6
|
(10)
|
(10)
|
(104)
|
(98)
|
(81)
|
(84)
|
(277)
|
(310)
|
(336)
|
(336)
|
(48)
|
(84)
|
(60)
|
(65)
|
(67)
|
(30)
|
(51)
|
(68)
|
(129)
|
(103)
|
(82)
|
(60)
|
(391)
|
(396)
|
(388)
|
(374)
|
17
|
25
|
19
|
9
|
9
|
7
|
(4)
|
(56)
|
|
| Cashflow aus Investitionstätigkeit |
(20)
N/A
|
(86)
-332%
|
(85)
+1%
|
(179)
-111%
|
(173)
+3%
|
(103)
+40%
|
(110)
-7%
|
(308)
-180%
|
(348)
-13%
|
(374)
-7%
|
(382)
-2%
|
(93)
+76%
|
(124)
-33%
|
(103)
+17%
|
(106)
-3%
|
(109)
-3%
|
(79)
+28%
|
(107)
-35%
|
(129)
-21%
|
(191)
-48%
|
(161)
+16%
|
(129)
+20%
|
(99)
+23%
|
(426)
-330%
|
(433)
-2%
|
(427)
+1%
|
(415)
+3%
|
(24)
+94%
|
(17)
+30%
|
(21)
-24%
|
(30)
-42%
|
(32)
-9%
|
(33)
-4%
|
(46)
-37%
|
(98)
-114%
|
|
| Finanzierungs-Cashflow | ||||||||||||||||||||||||||||||||||||
| Nettoausgabe von Stammaktien |
0
|
0
|
0
|
108
|
108
|
108
|
108
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Nettoaufnahme von Schulden |
(21)
|
95
|
83
|
165
|
164
|
44
|
57
|
116
|
172
|
182
|
233
|
104
|
106
|
102
|
52
|
50
|
3
|
(7)
|
(26)
|
(26)
|
14
|
(6)
|
(71)
|
320
|
235
|
227
|
294
|
(143)
|
(65)
|
(73)
|
(108)
|
(40)
|
(75)
|
(20)
|
62
|
|
| Gezahlte Dividenden |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(41)
|
(41)
|
(41)
|
0
|
(43)
|
(43)
|
(43)
|
0
|
(47)
|
(47)
|
(47)
|
0
|
(117)
|
(117)
|
(117)
|
0
|
(57)
|
(57)
|
(57)
|
0
|
0
|
(47)
|
(47)
|
0
|
0
|
(48)
|
(48)
|
|
| Sonstiges |
(108)
|
(81)
|
(91)
|
(51)
|
(31)
|
(14)
|
0
|
2
|
(3)
|
(4)
|
(7)
|
(7)
|
(8)
|
(8)
|
(23)
|
(23)
|
(23)
|
(23)
|
(8)
|
(7)
|
(7)
|
(7)
|
(12)
|
(13)
|
(18)
|
(34)
|
(33)
|
(50)
|
(51)
|
(54)
|
(54)
|
(55)
|
(61)
|
(62)
|
(59)
|
|
| Cashflow aus Finanzierungstätigkeit |
(129)
N/A
|
14
N/A
|
(8)
N/A
|
221
N/A
|
241
+9%
|
137
-43%
|
164
+20%
|
118
-28%
|
128
+8%
|
136
+6%
|
184
+35%
|
55
-70%
|
54
-2%
|
50
-7%
|
(14)
N/A
|
(15)
-10%
|
(67)
-335%
|
(77)
-14%
|
(81)
-5%
|
(81)
+0%
|
(109)
-36%
|
(129)
-18%
|
(200)
-55%
|
190
N/A
|
160
-16%
|
137
-14%
|
205
+49%
|
(249)
N/A
|
(115)
+54%
|
(174)
-51%
|
(209)
-20%
|
(142)
+32%
|
(183)
-29%
|
(131)
+29%
|
(46)
+65%
|
|
| Veränderung der Zahlungsmittel | ||||||||||||||||||||||||||||||||||||
| Effekt von Wechselkursänderungen |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
1
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
|
| Nettoveränderung der Zahlungsmittel |
(29)
N/A
|
12
N/A
|
(6)
N/A
|
162
N/A
|
204
+26%
|
199
-3%
|
214
+7%
|
(74)
N/A
|
(111)
-50%
|
(148)
-33%
|
(97)
+34%
|
76
N/A
|
28
-63%
|
51
+79%
|
11
-78%
|
15
+31%
|
18
+20%
|
25
+43%
|
41
+62%
|
(19)
N/A
|
(21)
-9%
|
12
N/A
|
(10)
N/A
|
86
N/A
|
30
-65%
|
(13)
N/A
|
8
N/A
|
(96)
N/A
|
55
N/A
|
1
-98%
|
(37)
N/A
|
(2)
+94%
|
(3)
-41%
|
28
N/A
|
82
+190%
|
|
| Free Cashflow | ||||||||||||||||||||||||||||||||||||
| Free Cashflow |
95
N/A
|
8
-92%
|
12
+50%
|
45
+272%
|
62
+38%
|
143
+132%
|
133
-7%
|
85
-36%
|
71
-17%
|
52
-27%
|
54
+5%
|
69
+28%
|
58
-16%
|
61
+5%
|
91
+49%
|
97
+7%
|
115
+18%
|
153
+33%
|
189
+24%
|
190
+0%
|
191
+0%
|
222
+16%
|
250
+12%
|
287
+15%
|
266
-7%
|
239
-10%
|
177
-26%
|
136
-23%
|
146
+7%
|
157
+8%
|
163
+4%
|
131
-20%
|
175
+34%
|
164
-6%
|
187
+14%
|
|
Wechseln zu:
Wechseln zu:
Auch interessant
Other Dermapharm Holding SE listings:
Mehr entdecken
